Similar Papers

Paper Title
Journal
Date
Author
Cytogenetic and Molecular Responses At 3 Months Are Associated with A Better Outcome in Early Chronic Phase (ECP) Chronic Myeloid Leukemia (CML) Patients Treated with Nilotinib.
Gabriele Gugliotta ...
Blood | VOL. 120
Gabriele Gugliotta, et. al.Gabriele Gugliotta ...
16 Nov 2012
An Intron-Derived Insertion/Truncation Mutation in the BCR-ABL Kinase Domain in Chronic Myeloid Leukemia Patients Undergoing Kinase Inhibitor Therapy
Jennifer Laudadio ... Richard D Press
The Journal of Molecular Diagnostics | VOL. 10
Jennifer Laudadio, et. al.Jennifer Laudadio ... Richard D Press
01 Mar 2008
Early Molecular and Cytogenetic Responses Predicts for Significantly Longer Event Free Survival (EFS) and Overall Survival (OS) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) – an Analysis of 4 Tyrosine Kinase Inhibitor (TKI) Modalities (standard dose imatinib, high dose imatinib, dasatinib and nilotinib)
Preetesh Jain ... Jorge E Cortes
Blood | VOL. 120
Preetesh Jain, et. al.Preetesh Jain ... Jorge E Cortes
16 Nov 2012
Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients
Giuseppe Visani ... Patrizia Pregno
American Journal of Hematology | VOL. 85
Giuseppe Visani, et. al.Giuseppe Visani ... Patrizia Pregno
10 Nov 2010
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Comments on The Study of Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma
Yue-Can Zeng ... Yi Wang
Annals of Oncology | VOL. -
Yue-Can Zeng, et. al.Yue-Can Zeng ... Yi Wang
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.